NanoViricides Inc. (NNVC)

[Echo20]

NNVC:

From Dr Seymour:

Primates


We have no plans to do any primate work


We've developed a small animal model for MERS and will use that


Working on all of the pre-tox studies necessary to start the tox program


You will hear more about those studies shortly


Once they're done, the drug is locked and into tox we go!


EUGENE SEYMOUR, MD, MPH
Chief Executive Officer
NANOVIRICIDES, INC
Nanotechnology-based targeted anti-viral therapeutics

http://www.nanoviricides.com
[e-mail]
310-486-5677

_____________________________________________________

Echo20